Maria Yazdanbakhsh Selected Research

Parasitic Diseases (Parasitic Disease)

1/2022	Intestinal permeability before and after albendazole treatment in low and high socioeconomic status schoolchildren in Makassar, Indonesia.
1/2021	Bee- and Wasp-Venom Sensitization in Schoolchildren of High- and Low-Socioeconomic Status Living in an Urban Area of Indonesia.
1/2019	Risk assessment for the implementation of controlled human Schistosoma mansoni infection trials in Uganda.
1/2016	IgG1 Fc N-glycan galactosylation as a biomarker for immune activation.
7/2015	Chronic helminth infection and helminth-derived egg antigens promote adipose tissue M2 macrophages and improve insulin sensitivity in obese mice.
9/2013	Peanut-specific IgE antibodies in asymptomatic Ghanaian children possibly caused by carbohydrate determinant cross-reactivity.
6/2012	A pilot study on cytotoxic T lymphocyte-4 gene polymorphisms in urinary schistosomiasis.
11/2009	Determinants of the relationship between cytokine production in pregnant women and their infants.
1/2003	Parallels between parasite infections and specific immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Yazdanbakhsh Research Topics

Disease

80	Infections 01/2022 - 04/2002
14	Hypersensitivity (Allergy) 01/2021 - 04/2002
14	Malaria 01/2021 - 01/2007
12	Schistosomiasis (Bilharziasis) 01/2021 - 03/2004
9	Parasitic Diseases (Parasitic Disease) 01/2022 - 01/2003
7	Insulin Resistance 01/2021 - 01/2015
5	Coinfection 01/2021 - 06/2008
5	Filarial Elephantiasis (Lymphatic Filariasis) 03/2014 - 11/2003
4	Cicatrix (Scar) 01/2019 - 10/2007
4	Reinfection 12/2018 - 11/2002
4	Inflammation (Inflammations) 01/2016 - 06/2007
4	Tuberculosis (Tuberculoses) 11/2010 - 01/2007
3	Schistosomiasis mansoni 01/2020 - 01/2018
3	Autoimmune Diseases (Autoimmune Disease) 10/2017 - 02/2005
2	Neglected Diseases 07/2021 - 12/2017
2	Hookworm Infections (Hookworm Infection) 01/2021 - 05/2014
2	Asthma (Bronchial Asthma) 01/2021 - 04/2011
2	Overweight 01/2021 - 01/2020
2	Parasitemia 01/2021 - 01/2013
2	Granuloma 01/2018 - 01/2013
2	Trichuriasis 01/2017 - 05/2014
2	Tetanus 04/2013 - 04/2012
2	Atopic Dermatitis (Atopic Eczema) 04/2011 - 06/2005
2	Poliomyelitis (Polio) 05/2010 - 01/2008
2	Filariasis 08/2006 - 11/2003
1	Obesity 01/2021
1	Neoplasms (Cancer) 01/2021
1	Malnutrition (Nutritional Deficiencies) 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Bites and Stings (Sting) 01/2021
1	Food Hypersensitivity (Food Allergy) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Urticaria (Hives) 01/2019
1	Rhinitis 01/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	Dermatitis 01/2019
1	Communicable Diseases (Infectious Diseases) 10/2018

Drug/Important Bio-Agent (IBA)

24	AntigensIBA 01/2021 - 08/2004
23	VaccinesIBA 07/2021 - 01/2007
21	CytokinesIBA 01/2021 - 04/2002
19	Immunoglobulin E (IgE)IBA 01/2021 - 11/2003
13	AllergensIBA 01/2021 - 04/2005
9	Immunoglobulin G (IgG)IBA 01/2019 - 11/2003
8	Interleukin-10 (Interleukin 10)IBA 01/2019 - 04/2002
6	Praziquantel (Biltricide)FDA Link 01/2021 - 11/2002
5	Albendazole (Albenza)FDA Link 01/2022 - 01/2013
5	AnthelminticsIBA 09/2017 - 04/2011
4	Polysaccharides (Glycans)IBA 01/2021 - 01/2012
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 03/2015
4	LipidsIBA 01/2020 - 11/2003
4	AntibodiesIBA 01/2017 - 11/2003
4	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2011 - 03/2004
4	BCG Vaccine FDA Link 11/2010 - 06/2007
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2009 - 03/2004
3	LeptinIBA 01/2021 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
3	Pharmaceutical PreparationsIBA 11/2020 - 12/2017
3	ChemokinesIBA 01/2019 - 02/2015
3	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 01/2019 - 06/2005
3	Glycoproteins (Glycoprotein)IBA 10/2017 - 01/2012
3	Antimalarials (Antimalarial Agents)IBA 05/2013 - 06/2008
3	InterleukinsIBA 01/2013 - 11/2002
3	LigandsIBA 01/2011 - 03/2004
3	Tuberculin (PPD)IBA 11/2010 - 10/2007
3	Vitamin A (Retinol)FDA LinkGeneric 09/2010 - 10/2007
2	Insulin-Like Growth Factor I (IGF-1)IBA 01/2021 - 11/2020
2	Hormones (Hormone)IBA 01/2021 - 01/2021
2	CholesterolIBA 01/2020 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2007
2	C-Reactive ProteinIBA 01/2018 - 01/2016
2	Biological ProductsIBA 01/2018 - 01/2015
2	Type II Tumor Necrosis Factor ReceptorsIBA 01/2017 - 05/2013
2	C-Type Lectins (C-Type Lectin)IBA 01/2016 - 09/2012
2	DNA (Deoxyribonucleic Acid)IBA 03/2014 - 05/2013
2	Interleukin-5 (Interleukin 5)IBA 01/2013 - 11/2002
2	OvalbuminIBA 01/2012 - 10/2007
2	LipopolysaccharidesIBA 09/2008 - 03/2004
2	Interferon-gamma (Interferon, gamma)IBA 09/2008 - 11/2002
2	Interleukin-6 (Interleukin 6)IBA 08/2006 - 03/2004
1	Insulin-Like PeptidesIBA 01/2021
1	AdiponectinIBA 01/2021
1	Bee Venoms (Bee Venom)IBA 01/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	EpitopesIBA 01/2021
1	Wasp Venoms (Venom, Wasp)IBA 01/2021
1	SugarsIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	InterferonsIBA 01/2021
1	CarbohydratesIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 11/2020
1	Carrier Proteins (Binding Protein)IBA 11/2020
1	Insulin-Like Growth Factor Binding Protein 3IBA 11/2020
1	oxidized low density lipoproteinIBA 01/2020
1	Lipoproteins (Lipoprotein)IBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2018
1	MitogensIBA 01/2018
1	Arachidonic Acid (Vitamin F)IBA 01/2018
1	dectin 1IBA 01/2018

Therapy/Procedure

4	Mass Drug Administration 07/2021 - 05/2014
2	Therapeutics 11/2011 - 10/2007